Braith R W, Mills R M, Wilcox C S, Convertino V A, Davis G L, Limacher M C, Wood C E
Department of Exercise and Sport Sciences, College of Health and Human Performance, University of Florida, Gainesville 32611, USA.
J Heart Lung Transplant. 1996 Sep;15(9):872-80.
Orthotopic heart transplantation may interrupt key neural and humoral homeostatic mechanisms that normally adjust Na+ and fluid excretion to changes in intake. Such an interruption could lead to plasma volume expansion.
We measured plasma volume and fluid regulatory hormones under standardized conditions in 11 heart transplant recipients (58 +/- 7 years old; mean +/- standard deviation) 21 +/- 4 months after transplantation, in 6 liver transplant recipients (51 +/- 6 years old) 13 +/- 8 months after transplantation (cyclosporine control group), and in 7 normal healthy control subjects (61 +/- 9 years old). Administration of all diuretics and antihypertensive drugs was discontinued before the study. After 3 days during which subjects ate a constant diet containing 87 mEq of Na+ per 24 hours, plasma volume was measured by a modified Evans blue dye (T-1824) dilution technique. Renal creatinine clearance was measured and blood samples were drawn for determination of plasma levels of vasopressin, angiotensin II, aldosterone, atrial natriuretic peptide, and plasma renin activity.
Supine resting plasma renin activity, angiotensin II, and aldosterone (renin-angiotensin-aldosterone axis) and vasopressin levels were not different among the control, heart transplant, and liver transplant groups. However, there was a trend toward elevated angiotensin II (p < or = 0.08) and aldosterone (p < or = 0.08) levels in the heart transplant recipients. Atrial natriuretic peptide levels were significantly elevated two to threefold in the heart transplant recipients when compared with those in the two control groups. Blood volume, normalized for body weight (milliliters per kilogram), was significantly greater (14%) in the heart transplant recipients when compared with that in liver transplant recipients and normal healthy control subjects. Blood volume values did not differ (p > or = 0.05) between the two control groups.
Extracellular fluid volume expansion (+14%) occurs in clinically stable heart transplant recipients who become hypertensive. Although hyperactivity of the renin-angiotensin-aldosterone axis is not apparent during supine resting conditions, our data suggest that the renin-angiotensin-aldosterone system is not responsive to a hypervolemic stimulus and this is likely a consequence of chronic cardiac deafferentation. Thus, poor adaptation of the renin-angiotensin-aldosterone system to fluid retention may be partly responsible for the incidence and severity of posttransplantation hypertension in some heart transplant recipients.
原位心脏移植可能会中断关键的神经和体液稳态机制,这些机制通常会根据摄入量的变化来调节钠和液体的排泄。这种中断可能导致血浆容量扩张。
我们在标准化条件下,对11名心脏移植受者(年龄58±7岁;均值±标准差)移植后21±4个月、6名肝移植受者(年龄51±6岁)移植后13±8个月(环孢素对照组)以及7名正常健康对照者(年龄61±9岁)测量了血浆容量和液体调节激素。在研究前停用所有利尿剂和降压药。在受试者连续3天食用含每24小时87 mEq钠的固定饮食后,采用改良伊文思蓝染料(T - 1824)稀释技术测量血浆容量。测量肾肌酐清除率,并采集血样以测定血浆中血管加压素、血管紧张素II、醛固酮、心钠素的水平以及血浆肾素活性。
对照组、心脏移植组和肝移植组之间,仰卧位静息时的血浆肾素活性、血管紧张素II和醛固酮(肾素 - 血管紧张素 - 醛固酮轴)以及血管加压素水平并无差异。然而,心脏移植受者的血管紧张素II(p≤0.08)和醛固酮(p≤0.08)水平有升高趋势。与两个对照组相比,心脏移植受者的心钠素水平显著升高了两到三倍。按体重归一化后的血容量(每千克毫升数),心脏移植受者比肝移植受者和正常健康对照者显著更高(高14%)。两个对照组之间的血容量值无差异(p≥0.05)。
在临床上稳定的高血压心脏移植受者中会出现细胞外液容量扩张(增加14%)。尽管在仰卧位静息状态下肾素 - 血管紧张素 - 醛固酮轴的活性不明显,但我们的数据表明肾素 - 血管紧张素 - 醛固酮系统对血容量过多刺激无反应,这可能是慢性心脏去传入神经作用的结果。因此,肾素 - 血管紧张素 - 醛固酮系统对液体潴留的适应性差可能部分导致了一些心脏移植受者移植后高血压的发生率和严重程度。